Preventive factors, diagnosis, and management of injection-related endophthalmitis: a literature review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Link
https://link.springer.com/content/pdf/10.1007/s00417-022-05607-8.pdf
Reference141 articles.
1. CATT Research Group TCR, Martin DF, Maguire MG et al (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:1897–1908. https://doi.org/10.1056/NEJMoa1102673
2. Elman MJ, Qin H, Aiello LP et al (2012) Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: Three-year randomized trial results. Ophthalmology 119:2312–2318. https://doi.org/10.1016/j.ophtha.2012.08.022
3. Nguyen QD, Brown DM, Marcus DM et al (2012) Ranibizumab for diabetic macular edema: Results from 2 phase iii randomized trials: RISE and RIDE. Ophthalmology 119:789–801. https://doi.org/10.1016/j.ophtha.2011.12.039
4. Ogura Y, Roider J, Korobelnik JF et al (2014) Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study. Am J Ophthalmol 158:1032-1038.e2. https://doi.org/10.1016/J.AJO.2014.07.027
5. Jonas JB (2005) Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta Ophthalmol Scand 83:645–663
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Using a Smartphone-Based Chatbot for Postoperative Care After Intravitreal Injection During the COVID-19 Pandemic: Retrospective Cohort Study;JMIR Formative Research;2024-08-02
2. Endophthalmitis: a bibliometric study and visualization analysis from 1993 to 2023;Frontiers in Cellular and Infection Microbiology;2024-07-16
3. Drug Distribution After Intravitreal Injection: A Mathematical Model;Investigative Opthalmology & Visual Science;2024-04-03
4. No effect of real-world universal face masking on post-intravitreal injection endophthalmitis rate at a single tertiary academic center;Retina;2024-01-11
5. A real-world disproportionality analysis of anti-VEGF drugs from the FDA Adverse Event Reporting System;Expert Opinion on Drug Safety;2023-09-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3